Cargando…
Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potential
CD8+ T cells are key effector cells in adaptive immune responses against intracellular pathogens and cancer cells. Systemic drug treatments, like chemotherapy, may positively or negatively affect CD8+ T cell function. In this protocol, we describe robust and optimized ex vivo polyclonal activation a...
Autores principales: | Loo Yau, Helen, De Carvalho, Daniel D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164095/ https://www.ncbi.nlm.nih.gov/pubmed/34095863 http://dx.doi.org/10.1016/j.xpro.2021.100549 |
Ejemplares similares
-
Assessing lineage and cytolytic functional potential of murine tissue-resident innate lymphocytes
por: Nixon, Briana G., et al.
Publicado: (2023) -
Identification of Cytolytic CD161(−)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood
por: Hu, Dan, et al.
Publicado: (2013) -
The Cytolytic Activity of Vaginolysin Strictly Depends on Cholesterol and Is Potentiated by Human CD59
por: Zilnyte, Milda, et al.
Publicado: (2015) -
CD8(+) T cells control SIV infection using both cytolytic effects and non-cytolytic suppression of virus production
por: Policicchio, Benjamin B., et al.
Publicado: (2023) -
Protocol for generation of human peptide-specific primary CD8(+) T cell lines
por: Grant, Emma J., et al.
Publicado: (2022)